Alaffia Health
Category: AI in Healthcare
An AI-powered payment integrity platform that leverages agentic AI to automate the detection and correction of medical billing errors, fraud, waste, and abuse for healthcare payers. Alaffia Health was founded in 2020. The company is led by TJ Ademiluyi. Based in New York, USA. Team size: 50-100. Total funding raised: $73M. Latest round: Series B. Key investors include Transformation Capital, FirstMark Capital, General Catalyst, Anthemis Group, GingerBread Capital, Tau Ventures, Twine Ventures.
AMW Analysis
Alaffia Health is an AI-powered payment integrity platform that uses agentic AI to automate detection and correction of medical billing errors, fraud, waste, and abuse for healthcare payers. The company recently secured $55 million in Series B funding, bringing total funding to $73 million. The platform pairs autonomous software with clinician oversight, achieving 97 percent accuracy in clinical data extraction. Clients have realized over $120 million in savings, including 20 percent average cost reductions on high-cost claims. The funding round was led by existing investors including Transformation Capital, FirstMark Capital, General Catalyst, and others. The company targets the estimated $570 billion wasted annually on healthcare administration. This latest round indicates continued investor confidence in scaling the agentic AI approach to payment integrity, with a focus on replacing manual claim reviews with autonomous AI agents that process complex clinical documentation in real-time.
AMW analysis, generated from 2 tracked news signals.
- Founded
- 2020
- Headquarters
- New York, USA
- Team size
- 50-100
- Total funding
- $73M
Value proposition
Eliminates administrative waste and improper payments by replacing manual, labor-intensive claim reviews with autonomous AI agents that can process complex clinical documentation in real-time.
Products and solutions
Autodor (Integrated claim review SaaS platform), Autodor AI Agents™ (Custom-built autonomous AI coworkers for claims operations), Ask Autodor (Generative AI co-pilot for claims teams), Payment-Integrity-as-a-Service (Turnkey clinical review and recovery solution), Automated Clinical Reasoning & Intelligent Routing Engine
Unique value
Utilizes 'Agentic AI'—autonomous systems capable of navigating complex clinical nuance and coding rules to make decisions, rather than just flagging anomalies for human review.
Target customer
Commercial health insurance plans, Third-Party Administrators (TPAs), self-insured employers, and government agencies (Medicaid and Medicare Advantage).
Industries served
Healthcare, Health Insurance (Payers), Insurtech, Medical Billing & Coding
Technology advantage
Combines proprietary LLMs trained on vast medical claim datasets with deep domain expertise from its founders (a sibling duo with backgrounds in medical billing operations and high-stakes financial analysis).
How they differentiate
Utilizes 'Agentic AI' to perform autonomous clinical reasoning and claim reviews, moving beyond legacy rules-based engines and manual human-in-the-loop audits used by incumbents.
Main competitors
Cotiviti, Claris Health, Change Healthcare (Optum)
Key partnerships
Strategic investment partners including Transformation Capital, FirstMark Capital, and General Catalyst, Recognized as a 'Major Contender' in Everest Group’s Payment Integrity Solutions PEAK Matrix, Member of the Association for Community Affiliated Plans (ACAP)
Notable customers
Association for Community Affiliated Plans (ACAP) members, Commercial Health Plans, Third-Party Administrators (TPAs)
Major milestones
Named a 'Major Contender' in Everest Group’s 2025 Payment Integrity Solutions PEAK Matrix, Launched 'Autodor AI Agents' for autonomous claims operations in 2024, Closed $55M Series B funding round in February 2026 to scale agentic AI capabilities, Saved health plans $120 million in medical costs and counting
Growth metrics
Achieved 4x revenue growth in 2024; saved health plans $120M in medical costs; scaled team to 50+ employees with plans to reach 100+ by end of 2026.
Market positioning
AI-first challenger in the payment integrity and medical billing fraud detection space, targeting mid-to-large health plans and TPAs.
Geographic focus
North America (United States healthcare market)
Patents and IP
No specific public patents disclosed; holds registered trademarks for core AI products including Autodor AI Agents™.
About TJ Ademiluyi
TJ Ademiluyi is the Co-founder and CEO of Alaffia Health. Before launching the company in 2020, he spent five years at Goldman Sachs within the Investment Banking Division, progressing from Analyst to Associate. His experience in high-stakes financial analysis and capital markets provided the foundation for tackling the $570 billion waste problem in the US healthcare system. He was recognized in the Forbes 30 Under 30 Healthcare list in 2023.
Latest news about Alaffia Health
- Alaffia Health secured 55 million dollars in Series B funding to combat the 570 billion dollars wasted annually on healthcare administration. Their agentic AI platform pairs autonomous software with c
- Alaffia Health has secured 55 million dollars in Series B funding to scale its agentic AI platform designed to eliminate medical billing errors and fraud. By deploying autonomous AI agents that perfor
More AI in Healthcare companies
Official website: https://www.alaffiahealth.com
